NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Motor Neuron Disease


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Avanir Pharmaceuticals Announces Zenvia Safety and Efficacy Data from Star Trial Open Label Extension
2009 NOV 23 ... Clinical Trial Research, Dextromethorphan, Excitatory Amino Acid Antagonist, FDA, Motor Neuron Disease, Neurology, Pharmaceutical Business, Pharmaceutical Company, Quinidine, Therapy, ...
Subject: AVANIR Pharmaceuticals, Inc.
Price: $3.00
*
CytRx Reports 2009 Third Quarter Financial Results
2009 NOV 23 ... Trial Research, Drug Development, Drugs, Hematology, Lou Gehrig Disease, Mental Health, Motor Neuron Disease, Neurodegenerative, Neurology, Oncology, Pharmaceuticals, Promyelocytic Leukemia, ...
Subject: CytRx Corporation
Price: $3.00
*
Data on amyotrophic lateral sclerosis reported by researchers at University of Massachusetts, Medical Department
2009 NOV 23 ... Amyotrophic Lateral Sclerosis, Biological Chemistry, Copper, Dismutase, Drugs, Enzymes, Motor Neuron Disease, Neurology, Neuron Degeneration, Pharmaceuticals, Therapy, Treatment, University of ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Data on drug delivery detailed by researchers at Emory University
2009 NOV 16 ... Gene Therapy, Genetics, Genomics, Molecular Pharmacology, Molecular Therapies, Motor Neuron Disease, Neurology, Neurosurgery, Surgery, Therapy, Treatment, Emory University. ...
Subject: Drug Delivery
Price: $3.00
*
Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
2009 NOV 23 ... Lateral Sclerosis, Antiinflammatory, Drug Development, FDA, Lou Gehrig Disease, Motor Neuron Disease, Multiple Sclerosis, Neuroimmunology, Neurology, Regulatory Actions, Therapy, Treatment, ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Investigators at University of Science and Technology zero in on life sciences
2009 NOV 16 ... Disease, Central Nervous System Disease, Mental Health, Neurodegenerative, Neurology, Motor Neuron Disease, Dismutase, Enzymes, Ligase, Genetics, Ataxia. This article was prepared by ...
Subject: Life Sciences
Price: $3.00
*
New amyotrophic lateral sclerosis study findings recently were reported by M.A. Vanes and co-researchers
2009 NOV 23 ... Keywords: City:Utrecht, Country:Netherlands, Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Neurology. This article was prepared by Pain & Central Nervous System Week ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
New amyotrophic lateral sclerosis study results reported from ANZAC Research Institute
2009 NOV 16 ... Keywords: Australia, Amyotrophic Lateral Sclerosis, DNA, Mental Health, Motor Neuron Disease, Neurodegenerative, Neurology, Neurosurgery, Psychiatry. This article was ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
New motor neuron disease study results from University of Oxford described
2009 NOV 23 ... MA, USA. Keywords: City:Oxford, Country:United Kingdom, Chronic Disease, Motor Neuron Disease, Neurology, Speech, University of Oxford. This article was prepared by Pain ...
Subject: Motor Neuron Disease
Price: $3.00
*
New muscular atrophy study findings have been reported from University of Milan
2009 NOV 16 ... DC 20036, USA. Keywords: Italy, Milan, Charcot-Marie-Tooth Disease, Motor Neuron Disease, Neurology, Neuroscience, Pharmaceuticals, Pharmacological, Spinal Muscular Atrophy, ...
Subject: Muscular Atrophy
Price: $3.00
*
Recent findings from University of Zagreb, Medical Department highlight research in amyotrophic lateral sclerosis
2009 NOV 23 ... Keywords: City:Zagreb, Country:Croatia, Amyotrophic Lateral Sclerosis, Laminectomy, Motor Neuron Disease, Neurology, Spinal Cord Disease, Spinal Curvatures, Spinal Osteophytosis, Surgery, ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Research findings from Michigan Technological University update understanding of amyotrophic lateral sclerosis
2009 NOV 16 ... Keywords: United States, Houghton, Amyotrophic Lateral Sclerosis, Genetics, Motor Neuron Disease, Neurology, Neuromuscular Disease, Michigan Technological University. This ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Research on amyotrophic lateral sclerosis discussed by scientists at Linkoping University
2009 NOV 9 ... Amyotrophic Lateral Sclerosis, Biochemistry, Copper, Dismutase, Drugs, Enzyme Research, Motor Neuron Disease, Neurology, Pharmaceuticals, Physiology, Protein Interaction, Proteins, Proteomics, ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Studies from P. Vandamme et al provide new data on amyotrophic lateral sclerosis
2009 NOV 23 ... and colleagues published their study in Current Opinion in Neurology (Recent advances in motor neuron disease. Current Opinion in Neurology, 2009;22(5):486-492). Additional information ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*
Study data from J. Vogt and colleagues update understanding of multiple sclerosis
2009 NOV 16 ... in MS patients, including assessment of compound muscle action potentials and motor unit numbers and quantified neuronal cell loss in human MS samples and different EAE ... Vogt and colleagues published their study in Annals of Neurology (Lower Motor Neuron Loss in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Annals of ... "Multiple sclerosis (MS) is considered a chronic inflammatory and demyelinating disease of the central nervous system. Evidence that axonal and neuronal pathology contributes ...
Subject: Multiple Sclerosis
Price: $3.00
*
Study data from University of Texas provide new insights into biological chemistry
2009 NOV 27 ... Dementia, Central Nervous System Disease, Amyotrophic Lateral Sclerosis, Neurology, Motor Neuron Disease, Biological Chemistry, University of Texas.This article was prepared by ...
Subject: Biological Chemistry
Price: $3.00
*
Study results from University of Oxford broaden understanding of amyotrophic lateral sclerosis
2009 NOV 16 ... amyotrophic lateral sclerosis (ALS). A mutation screen and copy number analysis in a motor neuron disease clinic cohort was conducted to characterise the genetic contribution of TARDBP." ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
In Cart
University of Kentucky describes research in amyotrophic lateral sclerosis genetics
2009 NOV 9 ... Lateral Sclerosis, Copper, Dismutase, Drugs, Enzyme Research, Genetics, Mental Health, Motor Neuron Disease, Neurochemistry, Neurodegenerative, Neurodegenerative Disease, Neurology, ...
Subject: Amyotrophic Lateral Sclerosis Genetics
View Free
Daily News
Article
University of Washington reports research in amyotrophic lateral sclerosis
2009 NOV 23 ... Amyotrophic Lateral Sclerosis, Behavior, CuZn Superoxide Dismutase, Dismutase, Enzymes, Motor Neuron Disease, Neurology, Therapy, Treatment, University of Washington. This article was ...
Subject: Amyotrophic Lateral Sclerosis
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login